Macitentan: entry-into-humans study with a new endothelin receptor antagonist

被引：0
|
作者：
Patricia N. Sidharta
Paul L. M. van Giersbergen
Atef Halabi
Jasper Dingemanse
机构：
[1] Actelion Pharmaceuticals Ltd,Department of Clinical Pharmacology
[2] Clinical Research Services Kiel GmbH,undefined
来源：
European Journal of Clinical Pharmacology | 2011年 / 67卷
关键词：
Endothelin receptor antagonist; Healthy subjects; Pharmacokinetics; Pharmacodynamics; Tolerability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：977 / 984
页数：7
相关论文
共 50 条
  • [1] Macitentan: entry-into-humans study with a new endothelin receptor antagonist
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Halabi, Atef
    Dingemanse, Jasper
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (10) : 977 - 984
  • [2] Entry-into-humans study with tezosentan, an intravenous dual endothelin receptor antagonist
    Dingemanse, J
    Clozel, M
    van Giersbergen, PLM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 39 (06) : 795 - 802
  • [3] Entry-into-humans study with a new direct renin inhibitor
    Laurent B. Nicolas
    Marcelo M. Gutierrez
    Christoph Binkert
    Jasper Dingemanse
    European Journal of Clinical Pharmacology, 2012, 68 : 1257 - 1266
  • [4] Entry-into-humans study with a new direct renin inhibitor
    Nicolas, Laurent B.
    Gutierrez, Marcelo M.
    Binkert, Christoph
    Dingemanse, Jasper
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (09) : 1257 - 1266
  • [5] Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans
    Bruderer, Shirin
    Hopfgartner, Gerard
    Seiberling, Michael
    Wank, Janine
    Sidharta, Patricia N.
    Treiber, Alexander
    Dingemanse, Jasper
    XENOBIOTICA, 2012, 42 (09) : 901 - 910
  • [6] Absorption, Distribution, Metabolism, and Excretion of Macitentan, a Dual Endothelin Receptor Antagonist, in Humans
    Bruderer, Shirin
    Sidharta, Patricia N.
    Seiberling, Michael
    Treiber, Alexander
    Dingemanse, Jasper
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1341 - 1342
  • [7] A Novel Synthesis of Macitentan, an Endothelin Receptor Antagonist
    Nami, Majid
    Sovari, Sara Nasiri
    Haghighatnia, Yaghoub
    Dabiri, Minoo
    Salehi, Peyman
    ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 2017, 49 (03) : 258 - 264
  • [8] Macitentan - a special new Endothelin Receptor Antagonist is coming in front of the Door
    不详
    JOURNAL FUR KARDIOLOGIE, 2013, 20 (9-10): : 320 - 320
  • [9] Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
    Sidharta, P. N.
    Treiber, A.
    Dingemanse, J.
    CLINICAL PHARMACOKINETICS, 2015, 54 (05) : 457 - 471
  • [10] Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
    P. N. Sidharta
    A. Treiber
    J. Dingemanse
    Clinical Pharmacokinetics, 2015, 54 : 457 - 471
12345